rs17390445
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs17390445(A;A) |
| Make rs17390445(A;G) |
| Make rs17390445(G;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 4 |
| Position | 34892233 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs17390445 |
| dbSNP (classic) | rs17390445 |
| ClinGen | rs17390445 |
| ebi | rs17390445 |
| HLI | rs17390445 |
| Exac | rs17390445 |
| Gnomad | rs17390445 |
| Varsome | rs17390445 |
| LitVar | rs17390445 |
| Map | rs17390445 |
| PheGenI | rs17390445 |
| Biobank | rs17390445 |
| 1000 genomes | rs17390445 |
| hgdp | rs17390445 |
| ensembl | rs17390445 |
| geneview | rs17390445 |
| scholar | rs17390445 |
| rs17390445 | |
| pharmgkb | rs17390445 |
| gwascentral | rs17390445 |
| openSNP | rs17390445 |
| 23andMe | rs17390445 |
| SNPshot | rs17390445 |
| SNPdbe | rs17390445 |
| MSV3d | rs17390445 |
| GWAS Ctlg | rs17390445 |
| GMAF | 0.3508 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
One of the only SNPs in a large GWAS study to have statistical significance in terms of helping to predict anti-psychotic drug (ziprasidone in this case) response by schizophrenia patients.[PMID 19721433
]
| GWAS snp | |
|---|---|
| PMID | [PMID 19721433]
|
| Trait | Treatment response to antipsychotics |
| Title | Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics |
| Risk Allele | |
| P-val | 1E-7 |
| Odds Ratio | 17.00 [NR] % of variance explained |
[PMID 21162693] Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.
